Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers

Detalles Bibliográficos
Autores principales: Ge, Yuanlong, Wu, Shu, Zhang, Zepeng, Li, Xiaocui, Li, Feng, Yan, Siyu, Liu, Haiying, Huang, Junjiu, Zhao, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Higher Education Press 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881410/
https://www.ncbi.nlm.nih.gov/pubmed/31187422
http://dx.doi.org/10.1007/s13238-019-0640-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881410/
https://www.ncbi.nlm.nih.gov/pubmed/31187422
http://dx.doi.org/10.1007/s13238-019-0640-1

Ejemplares similares